Valvular heart disease and fibrotic reactions may be related to ergot dopamine agonists, but non-ergot agonists may also not be spared.

摘要

Companion letters have been published in this issue of Movement Disorders: Horowski et al., pp 1523-1524, and Rascol et al., pp 1524-1525.